REVISION THERAPEUTICS INC has a total of 21 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are THESAN PHARMACEUTICALS INC, CANCER VACCINE INST and SYNVISTA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mata Nathan L | 15 |
#2 | Lichter Jay | 11 |
#3 | Widder Kenneth | 9 |
#4 | Haddach Mustapha | 6 |
#5 | Phan Kim B | 6 |
#6 | Bui Tam V | 6 |
#7 | Vogel Roger | 2 |
#8 | Edgar Mark | 2 |
#9 | Reid Silvia N | 2 |
#10 | Han Yun | 2 |
Publication | Filing date | Title |
---|---|---|
EP2648711A2 | Compositions and methods for treating ophthalmic conditions | |
EP2521541A2 | Prophylaxis of skin cancer with retinamides | |
WO2010129486A1 | Methods and compositions for treating ophthalmic conditions | |
US2009088435A1 | Methods and compounds for treating retinol-related diseases |